EBITDA: Income before interest, taxes, depreciation and amortization.
Via Pharmaceuticals Inc. (VIAP) had EBITDA of $-4.27M for the most recently reported fiscal year, ending 2010-12-31.
| Income Statement Financials | |
-- |
|
$-9.60M |
|
-- |
|
-- |
|
$5.90M |
|
$-5.90M |
|
$-3.68M |
|
$-9.60M |
|
$-9.60M |
|
$-9.60M |
|
$-9.49M |
|
$-9.49M |
|
$-9.60M |
|
$-5.90M |
|
|
EBITDA |
$-4.27M |
20.40M |
|
20.40M |
|
$-0.47 |
|
$-0.47 |
|
| Balance Sheet Financials | |
$0.44M |
|
$0.02M |
|
$0.05M |
|
$0.49M |
|
$18.98M |
|
-- |
|
$0.01M |
|
$18.99M |
|
$-18.50M |
|
$-18.50M |
|
$-18.49M |
|
-- |
|
| Cash Flow Statement Financials | |
$-6.10M |
|
$0.00M |
|
$4.00M |
|
$2.19M |
|
$0.08M |
|
$-2.10M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.02 |
|
-- |
|
-- |
|
-- |
|
-0.76 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.10M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
51.32% |
|
51.32% |
|
-1937.55% |
|
51.35% |
|
-- |
|
$-0.30 |
|
$-0.30 |
|